Literature DB >> 22986995

Mania: diagnosis and treatment recommendations.

Gin S Malhi1, Michelle Tanious, Michael Berk.   

Abstract

This article provides recommendations for the diagnosis and treatment of mania, which characterizes bipolar I disorder (BD I). Failure to detect mania leads to misdiagnosis and suboptimal treatment. To diagnose mania, clinicians should include a detailed mood history within their assessment of patients presenting with depression, agitation, psychosis or insomnia. With regards to treatment, by synthesizing the findings from recent treatment guidelines, and reviewing relevant literature, this paper has distilled recommendations for both acute and long-term management. Antimanic agents including atypical antipsychotics and traditional mood stabilizers are employed to reduce acute manic symptoms, augmented by benzodiazepines if needed, and in refractory or severe cases with behavioural and/or psychotic disturbance, electroconvulsive therapy may occasionally be necessary. Maintenance/prophylaxis therapy aims to reduce recurrences/relapse, for which the combination of psychological interventions with pharmacotherapy is beneficial as it ensures adherence and monitoring of tolerability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986995     DOI: 10.1007/s11920-012-0324-5

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  71 in total

1.  Interpersonal psychotherapy: principles and applications.

Authors:  John C Markowitz; Myrna M Weissman
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

Review 2.  DSM categories and dimensions in clinical and research contexts.

Authors:  Helena Chmura Kraemer
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

Review 3.  Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions.

Authors:  David J Miklowitz; Jan Scott
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

Review 4.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

5.  Group-based psychosocial intervention for bipolar disorder: randomised controlled trial.

Authors:  David Castle; Carolynne White; James Chamberlain; Michael Berk; Lesley Berk; Sue Lauder; Greg Murray; Isaac Schweitzer; Leon Piterman; Monica Gilbert
Journal:  Br J Psychiatry       Date:  2010-05       Impact factor: 9.319

6.  Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.

Authors:  Ross J Baldessarini; Leonardo Tondo; Paula Davis; Maurizio Pompili; Frederick K Goodwin; John Hennen
Journal:  Bipolar Disord       Date:  2006-10       Impact factor: 6.744

7.  The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study.

Authors:  Rafael Thomaz da Costa; Elie Cheniaux; Pedro Augusto Legnani Rosaes; Marcele Regine de Carvalho; Rafael Christophe da Rocha Freire; Márcio Versiani; Bernard Pimentel Rangé; Antonio Egidio Nardi
Journal:  Braz J Psychiatry       Date:  2011-06       Impact factor: 2.697

8.  The clinical history and costs associated with delayed diagnosis of bipolar disorder.

Authors:  Paul E Stang; Cathy Frank; Anupama Kalsekar; Marianne Ulcickas Yood; Karen Wells; Steven Burch
Journal:  MedGenMed       Date:  2006-04-19

9.  Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder.

Authors:  Dan Chisholm; Mark van Ommeren; Jose-Luis Ayuso-Mateos; Shekhar Saxena
Journal:  Br J Psychiatry       Date:  2005-12       Impact factor: 9.319

10.  Is cognitive-behavioural therapy more effective than psychoeducation in bipolar disorder?

Authors:  Ari Zaretsky; William Lancee; Cheryl Miller; Andrea Harris; Sagar V Parikh
Journal:  Can J Psychiatry       Date:  2008-07       Impact factor: 4.356

View more
  3 in total

Review 1.  Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?

Authors:  Gabriele Sani; Giulio Perugi; Leonardo Tondo
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

2.  Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.

Authors:  William V Bobo; Noreen A Reilly-Harrington; Terence A Ketter; Benjamin D Brody; Gustavo Kinrys; David E Kemp; Richard C Shelton; Susan L McElroy; Louisa G Sylvia; James H Kocsis; Melvin G McInnis; Edward S Friedman; Vivek Singh; Mauricio Tohen; Charles L Bowden; Thilo Deckersbach; Joseph R Calabrese; Michael E Thase; Andrew A Nierenberg; Dustin J Rabideau; David A Schoenfeld; Stephen V Faraone; Masoud Kamali
Journal:  J Affect Disord       Date:  2014-03-13       Impact factor: 4.839

3.  Towards the clinical implementation of pharmacogenetics in bipolar disorder.

Authors:  Naji C Salloum; Michael J McCarthy; Susan G Leckband; John R Kelsoe
Journal:  BMC Med       Date:  2014-05-30       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.